Senior Analyst to Follow Specialty Pharmaceuticals Industry

JMP Group LLC (NYSE:JMP), an investment banking and alternative asset management firm, announced today that Donald Ellis has joined JMP Securities as a managing director and equity research analyst covering specialty pharmaceuticals.

“Don is a seasoned research analyst with a broad range of experience in the biopharmaceutical industry,” said Thomas Wright, director of equities at JMP Securities. “As a Wall Street veteran, a clinical pharmacologist and an entrepreneur, he is extraordinarily well positioned to provide JMP’s institutional brokerage clients with insight into the specialty pharmaceuticals sector. Don’s arrival brings the number of senior equity analysts focused on life sciences at JMP to six and underscores the firm’s commitment to being a leading resource for institutional investors and growth companies in the space.”

Prior to joining JMP Securities, Mr. Ellis was a managing director and equity research analyst at Avondale Partners. Previously, he founded and ran a capital markets consulting firm, after spending 15 years in senior research positions at boutique investment banks Thomas Weisel Partners, Robertson Stephens & Co. and Montgomery Securities. Earlier in his career, Mr. Ellis spent 11 years in clinical practice at Kaiser Permanente and the VA Medical Center managing drug therapies and developing novel treatment protocols. He holds an MBA from the University of San Diego and a doctorate degree in pharmacy from the University of Southern California.

About JMP Group

JMP Group LLC is an investment banking and asset management firm that provides investment banking, equity research, and sales and trading services to corporate and institutional clients as well as alternative asset management products and services to institutional and high-net-worth investors. JMP Group conducts its investment banking and research, sales and trading activities through JMP Securities; its hedge fund and other investment activities though Harvest Capital Strategies; the underwriting and management of investments in senior secured debt through JMP Credit Advisors; and the management of Harvest Capital Credit Corporation (NASDAQ: HCAP), a business development company that finances small and midsized businesses, through HCAP Advisors. For more information, visit www.jmpg.com.

Investor Relations ContactJMP Group LLCAndrew Palmer, 415-835-8978apalmer@jmpg.comorMedia Relations ContactsDukas Public RelationsSeth Linden, 212-704-7385seth@dukaspr.comZach Leibowitz, 212-704-7385zach@dukaspr.com

JMP (NYSE:JMP)
Historical Stock Chart
From Sep 2024 to Oct 2024 Click Here for more JMP Charts.
JMP (NYSE:JMP)
Historical Stock Chart
From Oct 2023 to Oct 2024 Click Here for more JMP Charts.